Challenges to delivering evidence-based management for long COVID.
作者信息
Peiris Sasha, Izcovich Ariel, Ordunez Pedro, Luciani Silvana, Martinez Carmen, Aldighieri Sylvain, Reveiz Ludovic
机构信息
Pan American Health Organization, Washington, District of Columbia, USA.
Pan American Health Organization, Washington, District of Columbia, USA
出版信息
BMJ Evid Based Med. 2023 Oct;28(5):295-298. doi: 10.1136/bmjebm-2023-112311. Epub 2023 Jul 25.
Abstract
摘要
相似文献
1
Challenges to delivering evidence-based management for long COVID.
BMJ Evid Based Med. 2023 Oct;28(5):295-298. doi: 10.1136/bmjebm-2023-112311. Epub 2023 Jul 25.
2
Current landscape of long COVID clinical trials.
Int Immunopharmacol. 2024 May 10;132:111930. doi: 10.1016/j.intimp.2024.111930. Epub 2024 Mar 27.
3
Association Between Duration of SARS-CoV-2 Positivity and Long COVID.
Clin Infect Dis. 2023 Nov 30;77(11):1531-1533. doi: 10.1093/cid/ciad434.
4
Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid.
Future Microbiol. 2022 May;17:551-571. doi: 10.2217/fmb-2022-0031. Epub 2022 Mar 10.
5
An Insight Into Pathophysiology, Epidemiology, and Management of Cardiovascular Complications of SARS-CoV-2 Infection, Post-acute COVID Syndrome, and COVID Vaccine.
Crit Pathw Cardiol. 2022 Sep 1;21(3):123-129. doi: 10.1097/HPC.0000000000000290. Epub 2022 Apr 28.
6
15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.
Front Immunol. 2023 Sep 12;14:1226622. doi: 10.3389/fimmu.2023.1226622. eCollection 2023.
7
Long COVID: what do we know now and what are the challenges ahead?
J R Soc Med. 2024 Jul;117(7):224-228. doi: 10.1177/01410768241262661. Epub 2024 Sep 23.
8
Association of SARS-CoV-2 infection and persistence with long COVID.
Lancet Respir Med. 2023 Jun;11(6):504-506. doi: 10.1016/S2213-2600(23)00142-X. Epub 2023 May 10.
9
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
Nat Immunol. 2023 Oct;24(10):1616-1627. doi: 10.1038/s41590-023-01601-2. Epub 2023 Sep 4.
10
Long-term complications of COVID-19.
Am J Physiol Cell Physiol. 2022 Jan 1;322(1):C1-C11. doi: 10.1152/ajpcell.00375.2021. Epub 2021 Nov 24.
引用本文的文献
1
The Effect of COVID-19 Vaccination on the Risk of Persistent Post-COVID-19 Condition: Cohort Study.
J Infect Dis. 2025 Jun 2;231(5):e941-e944. doi: 10.1093/infdis/jiaf133.
本文引用的文献
1
Author Correction: Long COVID: major findings, mechanisms and recommendations.
Nat Rev Microbiol. 2023 Jun;21(6):408. doi: 10.1038/s41579-023-00896-0.
2
Coding long COVID: characterizing a new disease through an ICD-10 lens.
BMC Med. 2023 Feb 16;21(1):58. doi: 10.1186/s12916-023-02737-6.
3
Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.
Lancet Child Adolesc Health. 2023 Apr;7(4):238-248. doi: 10.1016/S2352-4642(23)00020-2. Epub 2023 Feb 3.
4
Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.
Nat Med. 2023 Jan;29(1):226-235. doi: 10.1038/s41591-022-02116-3. Epub 2022 Dec 1.
5
STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol.
PLoS One. 2022 Nov 30;17(11):e0277936. doi: 10.1371/journal.pone.0277936. eCollection 2022.
6
Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
JAMA Netw Open. 2022 Nov 1;5(11):e2242106. doi: 10.1001/jamanetworkopen.2022.42106.
7
A Longitudinal Study of COVID-19 Sequelae and Immunity.
Ann Intern Med. 2022 Dec;175(12):W153. doi: 10.7326/L22-0331. Epub 2022 Nov 1.
8
Pathophysiology of Post-COVID syndromes: a new perspective.
Virol J. 2022 Oct 9;19(1):158. doi: 10.1186/s12985-022-01891-2.
9
Long-term cardiovascular outcomes of COVID-19.
Nat Med. 2022 Mar;28(3):583-590. doi: 10.1038/s41591-022-01689-3. Epub 2022 Feb 7.
10
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.
Front Microbiol. 2021 Jun 23;12:698169. doi: 10.3389/fmicb.2021.698169. eCollection 2021.
Zotero 插件